by NeOnc | Apr 15, 2025 | Press Releases
Main > Press Releases Press Releases | April 15, 2025 > NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical Markets Share On Facebook Share On X Share On Linkedin Copy URL Share Via Email NeOnc Technologies Global...
by NeOnc | Apr 14, 2025 | Press Releases
Main > Press Releases Press Releases | April 14, 2025 > NeOnc Expects Full Enrollment In Phase 2a Trial of NEO100-01 Share On Facebook Share On X Share On Linkedin Copy URL Share Via Email NeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising...
by NeOnc | Apr 10, 2025 | Press Releases
Main > Archives for NeOnc Press Releases | March 31, 2025 > NeOnc Executive Chairman Assumes Expanded Leadership Role Share On Facebook Share On X Share On Linkedin Copy URL Share Via Email NeOnc Technologies Holdings, Inc. Executive Chairman, Amir...
by NeOnc | Apr 8, 2025 | Press Releases
Main > Archives for NeOnc Press Releases | April 08, 2025 > NeOnc Nears Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy Share On Facebook Share On X Share On Linkedin Copy URL Share Via Email NeOnc Technologies Announces Near Completion of...
by NeOnc | Mar 31, 2025 | Press Releases
Main > Press Releases Press Releases | March 31, 2025 > NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 Share On Facebook Share On X Share On Linkedin Copy URL Share Via Email NeOnc Technologies Holdings, Inc. Receives...
by NeOnc | Mar 27, 2025 | Press Releases
Main > Press Releases Press Releases | March 27, 2025 > NeOnc Technologies Partners with CBCC Global Research for Clinical Trials on NEO100-01 Share On Facebook Share On X Share On Linkedin Copy URL Share Via Email NeOnc Technologies Expands Global Clinical...
